{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:25:41Z","timestamp":1759530341277},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-244x-12-220","type":"journal-article","created":{"date-parts":[[2012,12,5]],"date-time":"2012-12-05T18:12:04Z","timestamp":1354731124000},"source":"Crossref","is-referenced-by-count":9,"title":["Selective acquired long QT syndrome (saLQTS) upon risperidone treatment"],"prefix":"10.1186","volume":"12","author":[{"given":"Maciej Jakub","family":"Lazarczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahir A","family":"Bhuiyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panteleimon","family":"Giannakopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,5]]},"reference":[{"key":"1142_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/0092-8674(95)90358-5","volume":"80","author":"ME Curran","year":"1995","unstructured":"Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT: A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995, 80: 795-803. 10.1016\/0092-8674(95)90358-5.","journal-title":"Cell"},{"key":"1142_CR2","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1124\/pr.110.003723","volume":"62","author":"P Kannankeril","year":"2010","unstructured":"Kannankeril P, Roden DM, Darbar D: Drug-induced long QT syndrome. Pharmacol Rev. 2010, 62: 760-781. 10.1124\/pr.110.003723.","journal-title":"Pharmacol Rev"},{"key":"1142_CR3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0033-0620(03)80005-1","volume":"45","author":"S Viskin","year":"2003","unstructured":"Viskin S, Justo D, Halkin A, Zeltser D: Long QT syndrome caused by noncardiac drugs. Prog Cardiovasc Dis. 2003, 45: 415-427.","journal-title":"Prog Cardiovasc Dis"},{"key":"1142_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/01.yic.0000166405.49473.70","volume":"20","author":"C St\u00f6llberger","year":"2005","unstructured":"St\u00f6llberger C, Huber JO, Finsterer J: Antipsychotic drugs and QT prolongation. Int Clin Psychopharmacol. 2005, 20: 243-251. 10.1097\/01.yic.0000166405.49473.70.","journal-title":"Int Clin Psychopharmacol"},{"key":"1142_CR5","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1172\/JCI25539","volume":"115","author":"DM Roden","year":"2005","unstructured":"Roden DM, Viswanathan PC: Genetics of acquired long QT syndrome. J Clin Invest. 2005, 115: 2025-2032. 10.1172\/JCI25539.","journal-title":"J Clin Invest"},{"key":"1142_CR6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.yjmcc.2008.01.006","volume":"44","author":"JB Saenen","year":"2008","unstructured":"Saenen JB, Vrints CJ: Molecular aspects of the congenital and acquired Long QT Syndrome: clinical implications. Mol Cell Cardiol. 2008, 44: 633-646. 10.1016\/j.yjmcc.2008.01.006.","journal-title":"Mol Cell Cardiol"},{"key":"1142_CR7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s00109-003-0522-z","volume":"82","author":"AD Paulussen","year":"2004","unstructured":"Paulussen AD, Gilissen RA, Armstrong M, Doevendans PA, Verhasselt P, Smeets HJ, Schulze-Bahr E, Haverkamp W, Breithardt G, Cohen N, Aerssens J: Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients. J Mol Med (Berl). 2004, 82: 182-188. 10.1007\/s00109-003-0522-z.","journal-title":"J Mol Med (Berl)"},{"key":"1142_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/hup.1258","volume":"27","author":"Y Suzuki","year":"2012","unstructured":"Suzuki Y, Fukui N, Watanabe J, Ono S, Sugai T, Tsuneyama N, Saito M, Inoue Y, Someya T: QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone. Hum Psychopharmacol. 2012, 27: 39-42. 10.1002\/hup.1258.","journal-title":"Hum Psychopharmacol"},{"key":"1142_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00213-011-2188-5","volume":"216","author":"FD Yang","year":"2011","unstructured":"Yang FD, Wang XQ, Liu XP, Zhao KX, Fu WH, Hao XR, Zhang XL, Huang GS, Qu SC, Bai JS, Huang XF, Kosten TR, Zhang XY: Sex difference in QTc prolongation in chronic institutionalized patients with schizophrenia on long-term treatment with typical and atypical antipsychotics. Psychopharmacology (Berl). 2011, 216: 9-16. 10.1007\/s00213-011-2188-5.","journal-title":"Psychopharmacology (Berl)"},{"key":"1142_CR10","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.jacc.2009.06.005","volume":"54","author":"Y Nishio","year":"2009","unstructured":"Nishio Y, Makiyama T, Itoh H, et al: D85N, a KCNE1 polymorphism, is a disease-causing gene variant in long QT syndrome. J Am Coll Cardiol. 2009, 54: 812-819. 10.1016\/j.jacc.2009.06.005.","journal-title":"J Am Coll Cardiol"},{"key":"1142_CR11","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/sj.ejhg.5201866","volume":"15","author":"L Gouas","year":"2007","unstructured":"Gouas L, Nicaud V, Chaouch S, Berthet M, Forhan A, Tichet J, Tiret L, Balkau B, Guicheney P: Confirmation of associations between ion channel gene SNPs and QTc interval duration in healthy subjects. Eur J Hum Genet. 2007, 15: 974-979. 10.1038\/sj.ejhg.5201866.","journal-title":"Eur J Hum Genet"},{"key":"1142_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0022-2828(02)00286-9","volume":"35","author":"Tristani-Firouzi","year":"2003","unstructured":"Tristani-Firouzi , Sanguinetti MC: Structural determinants and biophysical properties of HERG and KCNQ1 channel gating. J Mol Cell Cardiol. 2003, 35: 27-35. 10.1016\/S0022-2828(02)00286-9.","journal-title":"J Mol Cell Cardiol"},{"key":"1142_CR13","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.hrthm.2010.03.038","volume":"7","author":"K Hayashi","year":"2010","unstructured":"Hayashi K, Shuai W, Sakamoto Y, Higashida H, Yamagishi M, Kupershmidt S: Trafficking-competent KCNQ1 variably influences the function of HERG long QT alleles. Heart Rhythm. 2010, 7: 973-980. 10.1016\/j.hrthm.2010.03.038.","journal-title":"Heart Rhythm"},{"key":"1142_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/01.jcp.0000104913.75206.62","volume":"24","author":"EP Harrigan","year":"2004","unstructured":"Harrigan EP, Miceli JJ, Anziano R, Watsky E, Reeves KR, Cutler NR, Sramek J, Shiovitz T, Middle M: A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition. J Clin Psychopharmacol. 2004, 24: 62-69. 10.1097\/01.jcp.0000104913.75206.62.","journal-title":"J Clin Psychopharmacol"},{"key":"1142_CR15","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/humu.21106","volume":"30","author":"PL Hedley","year":"2009","unstructured":"Hedley PL, J\u00f8rgensen P, Schlamowitz S, Wangari R, Moolman-Smook J, Brink PA, Kanters JK, Corfield VA, Christiansen M: The genetic basis of long QT and short QT syndromes: a mutation update. Hum Mutat. 2009, 30: 1486-1511. 10.1002\/humu.21106.","journal-title":"Hum Mutat"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-12-220.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-12-220\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-12-220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,13]],"date-time":"2016-07-13T01:49:34Z","timestamp":1468374574000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-12-220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1142"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-12-220","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]},"article-number":"220"}}